Jump Financial LLC Purchases Shares of 491,225 Teladoc Health, Inc. $TDOC

Key Points

• Jump Financial LLC has invested approximately $3.91 million in Teladoc Health, acquiring 491,225 shares during the first quarter.
• Analysts have lowered their price targets for Teladoc Health, with a consensus rating of "Hold" and an average price target of $9.80.
• Insiders have reportedly sold a total of 18,656 shares of Teladoc Health stock in the last 90 days, indicating some decrease in their positions.

Jump Financial LLC purchased a new position in Teladoc Health, Inc. (NYSE:TDOC - Free Report) during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 491,225 shares of the health services provider's stock, valued at approximately $3,910,000. Jump Financial LLC owned approximately 0.28% of Teladoc Health at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the business. SVB Wealth LLC acquired a new stake in Teladoc Health during the 1st quarter worth about $37,000. Banco Bilbao Vizcaya Argentaria S.A. grew its holdings in shares of Teladoc Health by 23.2% during the first quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 172,977 shares of the health services provider's stock valued at $1,389,000 after buying an additional 32,609 shares in the last quarter. BI Asset Management Fondsmaeglerselskab A S purchased a new position in shares of Teladoc Health during the first quarter valued at $50,000. Pinnacle Wealth Management LLC purchased a new position in shares of Teladoc Health during the first quarter valued at $442,000. Finally, Algert Global LLC increased its holdings in shares of Teladoc Health by 37.5% in the 1st quarter. Algert Global LLC now owns 47,350 shares of the health services provider's stock valued at $377,000 after purchasing an additional 12,920 shares during the period. 76.82% of the stock is currently owned by institutional investors.

Insider Activity

In other news, insider Adam C. Vandervoort sold 5,808 shares of Teladoc Health stock in a transaction that occurred on Monday, June 2nd. The shares were sold at an average price of $6.86, for a total value of $39,842.88. Following the transaction, the insider owned 69,773 shares of the company's stock, valued at $478,642.78. This trade represents a 7.68% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Fernando M. Rodrigues sold 4,174 shares of Teladoc Health stock in a transaction that occurred on Tuesday, June 3rd. The shares were sold at an average price of $6.91, for a total transaction of $28,842.34. The disclosure for this sale can be found here. Insiders have sold a total of 18,656 shares of company stock valued at $128,189 over the last 90 days. 0.58% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on TDOC. Wells Fargo & Company dropped their target price on Teladoc Health from $10.00 to $8.00 and set an "equal weight" rating on the stock in a report on Thursday, May 8th. Bank of America dropped their target price on Teladoc Health from $8.00 to $7.00 and set a "neutral" rating on the stock in a report on Wednesday, May 28th. Truist Financial dropped their target price on Teladoc Health from $10.00 to $9.00 and set a "hold" rating on the stock in a report on Tuesday, May 27th. Mizuho began coverage on Teladoc Health in a report on Friday, July 25th. They issued a "neutral" rating and a $10.00 target price on the stock. Finally, Evercore ISI upped their target price on Teladoc Health from $7.00 to $8.00 and gave the company an "in-line" rating in a report on Wednesday, July 9th. Six research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. Based on data from MarketBeat, Teladoc Health currently has an average rating of "Hold" and a consensus price target of $9.80.

Teladoc Health Stock Down 1.9%

NYSE TDOC traded down $0.15 during trading on Friday, hitting $7.74. 3,533,595 shares of the company traded hands, compared to its average volume of 5,769,362. Teladoc Health, Inc. has a 12 month low of $6.35 and a 12 month high of $15.21. The business has a fifty day simple moving average of $7.81 and a 200 day simple moving average of $7.99. The company has a current ratio of 2.67, a quick ratio of 2.58 and a debt-to-equity ratio of 0.70. The company has a market capitalization of $1.37 billion, a P/E ratio of -6.50 and a beta of 1.84.

Teladoc Health (NYSE:TDOC - Get Free Report) last announced its quarterly earnings results on Tuesday, July 29th. The health services provider reported ($0.19) EPS for the quarter, beating the consensus estimate of ($0.27) by $0.08. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.16%.The company had revenue of $631.90 million for the quarter, compared to the consensus estimate of $621.91 million. During the same quarter last year, the company posted ($0.38) earnings per share. The company's revenue for the quarter was down 1.6% compared to the same quarter last year. Teladoc Health has set its Q3 2025 guidance at -0.350--0.200 EPS. FY 2025 guidance at -1.350--1.000 EPS. As a group, sell-side analysts predict that Teladoc Health, Inc. will post -1.16 EPS for the current year.

Teladoc Health Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.